All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments
| Autor: | Tae Hyun Kim, Byung-Ho Nam, Seong Hoon Kim, In Joon Lee, Hyun Boem Kim, Ji Eun Choi, Young Hwan Ko, Joong-Won Park, Hae Moon |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Male
Cancer Research medicine.medical_specialty Carcinoma Hepatocellular Radiofrequency ablation Hepatocellular carcinoma Original Article – Clinical Oncology Gastroenterology law.invention 03 medical and health sciences 0302 clinical medicine law Recurrence Internal medicine Republic of Korea medicine Humans Stage (cooking) Prospective cohort study Aged Neoplasm Staging Retrospective Studies business.industry Liver Neoplasms Cancer General Medicine Middle Aged medicine.disease Combined Modality Therapy Surgery Transplantation Survival Rate Treatment Outcome Oncology 030220 oncology & carcinogenesis Cohort Cohort studies 030211 gastroenterology & hepatology Female Neoplasm Recurrence Local business Cohort study Follow-Up Studies |
| Zdroj: | Journal of Cancer Research and Clinical Oncology |
| ISSN: | 1432-1335 0171-5216 |
| Popis: | Purpose In clinical practice, most patients with hepatocellular carcinoma require subsequent treatments for remaining, progressing, or recurring tumors. We investigated all-treatment array and outcomes in an HCC cohort from initial diagnosis to death. Methods We enrolled 1687 consecutive patients with HCC who underwent initial diagnosis and treatment at the National Cancer Center, Korea, from January 2004 to December 2009. Results In total, 1357 patients (80.4%) showed RPRTs during median 20.4-month follow-up. Initial transplantation resulted in the least rate (32.3%) of RPRTs. Median treatment frequency was 3.0 times (range 1–20) and 382 patients (27.3%) received treatments ≥6 times. The median treatment frequency was different based on four factors (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink